Manfred Schmidt spends much of his time researching Genetic enhancement, Immunology, Genetics, Stem cell and Haematopoiesis. The various areas that Manfred Schmidt examines in his Genetic enhancement study include Insertional mutagenesis, Viral vector, Severe combined immunodeficiency and Transplantation. He has included themes like Long terminal repeat and Cell biology in his Viral vector study.
His biological study spans a wide range of topics, including T cell and Genetic transfer. His studies deal with areas such as Hematopoietic stem cell transplantation, Cancer research and Hematopoietic stem cell as well as Immunology. His Stem cell research incorporates elements of Primary immunodeficiency and Chronic granulomatous disease.
His primary scientific interests are in Genetic enhancement, Genetics, Immunology, Viral vector and Molecular biology. His Genetic enhancement study incorporates themes from Insertional mutagenesis, Haematopoiesis, Stem cell, Transgene and Transplantation. His Haematopoiesis research incorporates themes from Myeloid and Wiskott–Aldrich syndrome.
He interconnects Cytotoxic T cell, Hematopoietic stem cell transplantation and Cancer research in the investigation of issues within Immunology. While the research belongs to areas of Cancer research, Manfred Schmidt spends his time largely on the problem of Colorectal cancer, intersecting his research to questions surrounding Cell. His Molecular biology research includes elements of Ex vivo, In vivo, Gene expression profiling, Cas9 and Long terminal repeat.
Manfred Schmidt mainly investigates Gene, Cell biology, Genetics, Computational biology and Viral vector. In Gene, Manfred Schmidt works on issues like Haematopoiesis, which are connected to Progenitor cell and Myeloid. His work on Plasmid, DNA sequencing and Reference genome as part of general Genetics study is frequently connected to Profiling and Scalability, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His Computational biology research also works with subjects such as
Manfred Schmidt mostly deals with Cancer research, Genetics, Pandemic, Computational biology and Gene. In his works, Manfred Schmidt undertakes multidisciplinary study on Cancer research and Population. CRISPR, Transgene, Gene deletion, Colorectal cancer and Genetic heterogeneity are among the areas of Genetics where the researcher is concentrating his efforts.
Pandemic combines with fields such as Epidemiology, In patient, Environmental health, Anticipation and Outbreak in his investigation. His research in Computational biology intersects with topics in Genome, Nucleus, Nuclear pore and Enhancer, Transcription. In most of his Gene studies, his work intersects topics such as T cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
S. Hacein-Bey-Abina;C. Von Kalle;C. Von Kalle;M. Schmidt;M. P. McCormack.
Science (2003)
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Nathalie Cartier;Salima Hacein-Bey-Abina;Cynthia C. Bartholomae;Gabor Veres.
Science (2009)
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.
Marion G Ott;Manfred Schmidt;Kerstin Schwarzwaelder;Stefan Stein.
Nature Medicine (2006)
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
Steven J. Howe;Marc R. Mansour;Kerstin Schwarzwaelder;Cynthia Bartholomae.
Journal of Clinical Investigation (2008)
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.
Alessandra Biffi;Eugenio Montini;Laura Lorioli;Martina Cesani.
Science (2013)
Dissecting the genomic complexity underlying medulloblastoma
David T. W. Jones;Natalie Jäger;Marcel Kool;Thomas Zichner.
Nature (2012)
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
Stefan Stein;Marion G. Ott;Stephan Schultze-Strasser;Anna Jauch.
Nature Medicine (2010)
An unbiased genome-wide analysis of zinc-finger nuclease specificity
Richard Gabriel;Angelo Lombardo;Anne Arens;Jeffrey C Miller.
Nature Biotechnology (2011)
The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy
Eugenio Montini;Daniela Cesana;Manfred Schmidt;Francesca Sanvito.
Journal of Clinical Investigation (2009)
Stem-Cell Gene Therapy for the Wiskott–Aldrich Syndrome
Kaan Boztug;Manfred Schmidt;Adrian Schwarzer;Pinaki P. Banerjee.
The New England Journal of Medicine (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Charité - University Medicine Berlin
University College London
Brigham and Women's Hospital
Vita-Salute San Raffaele University
Vita-Salute San Raffaele University
MolMed (Italy)
Hong Kong University of Science and Technology
Necker-Enfants Malades Hospital
Vita-Salute San Raffaele University
University of Modena and Reggio Emilia
University of Crete
Wellesley College
Istituto Universitario Di Studi Superiori Di Pavia
Hebrew University of Jerusalem
University of Maryland, College Park
New York University
Scotland's Rural College
University of Liverpool
University of Montana
University of California, San Diego
Goddard Space Flight Center
Environment and Climate Change Canada
Brown University
Henry Ford Health System
Catholic University of the Sacred Heart
Rutgers, The State University of New Jersey